Pseudohypoparathyroidism Explained: PTH Resistance, Low Calcium, High Phosphate and Albright Hereditary Osteodystrophy

Introduction

Pseudohypoparathyroidism describes a group of rare disorders in which parathyroid hormone is produced, often in large amounts, but target tissues do not respond normally to its signal.

The biochemical picture can therefore look paradoxical:

yet:

The parathyroid glands are not failing.

Instead:

The kidney is a particularly important site of resistance. Failure of the normal renal response to PTH reduces phosphate excretion and contributes to impaired calcium and vitamin D physiology. (NCBI)

Some forms are associated with characteristic skeletal and developmental features historically called:

and some have resistance to other hormones, especially:

Modern diagnosis increasingly depends on identifying the underlying molecular or epigenetic defect rather than relying only on the older clinical subtype labels. (Nature)

Why The Name “Pseudohypoparathyroidism”?

The patient resembles someone with hypoparathyroidism because both disorders can cause:

and:

But:

True hypoparathyroidism

The problem is:

Pseudohypoparathyroidism

The problem is:

Therefore:

rather than low.

Normal Pth Action

Normally:

PTH acts mainly on:

Kidney

• renal calcium reabsorption ↑;
• renal phosphate reabsorption ↓;
• phosphate excretion ↑;
• 1α-hydroxylase activity ↑;
• calcitriol production ↑.

Bone

PTH signalling contributes to mobilization of calcium and regulation of bone turnover.

Intestine

PTH acts indirectly via calcitriol to increase calcium absorption.

Normal Pth Signal Transduction

This is an important advanced section.

Use:

This signalling pathway is central to several pseudohypoparathyroidism-related disorders. The international consensus describes molecular abnormalities affecting the PTH/PTHrP receptor–Gsα–cAMP signalling pathway as the basis for much of this disease spectrum. (Nature)

What Happens In Pth Resistance?

The parathyroids detect hypocalcemia and respond appropriately:

But the kidney does not respond normally.

Therefore:

and:

and overall:

which stimulates even more PTH.

The Vicious Cycle

Display as:

But because tissues remain resistant:

This explains why untreated patients can have markedly elevated PTH. (NCBI)

Classic Biochemical Pattern

Use this table:

Endotext similarly describes PTH resistance as hypocalcemia, hyperphosphatemia and increased PTH, with impaired phosphaturic responses. (NCBI)

Why Phosphate Is High

PTH normally tells the proximal renal tubule:

Therefore:

In PTH resistance:

This is an essential mechanism.

Why Calcium Falls

PTH resistance contributes to hypocalcemia through several effects:

• impaired calcitriol generation;
• reduced intestinal calcium absorption;
• impaired PTH-mediated mineral handling;
• failure of normal compensatory physiology.

Endotext notes that PTH resistance can reduce calcium mobilization and intestinal absorption while impairing renal handling. (NCBI)

Why Pth Becomes High

Use:

The problem is therefore not failure of secretion.

It is:

This makes PHP fundamentally different from primary hypoparathyroidism.

Diagnostic Starting Point

When a patient has confirmed hypocalcemia, ask:

PTH low / inappropriate normal

Think:

PTH high

PTH secretion is intact.

Then ask:

Phosphate As The Next Clue

PTH ↑ + PO₄ low

Commonly think:

• vitamin D deficiency;
• reduced intestinal calcium absorption;
• secondary hyperparathyroidism.

PTH ↑ + PO₄ high

Think:

• CKD;
• PTH resistance;
• severe phosphate load;
• other renal/mineral disorders.

Then use:

and:

to narrow the diagnosis.

Ckd Must Be Excluded

CKD frequently produces:

Therefore biochemical similarity can be considerable.

Before diagnosing pseudohypoparathyroidism:

If substantial CKD is present, CKD-MBD becomes a much more likely explanation.

CKD-MBD Explained

Vitamin D Deficiency Must Be Considered

Vitamin D deficiency commonly causes:

but because elevated PTH produces phosphaturia:

rather than high.

Therefore:

is much more compatible with vitamin D deficiency than classic PHP.

Vitamin D Deficiency Explained

Magnesium

Severe magnesium deficiency may alter:

• PTH secretion;
• PTH action.

But severe hypomagnesemia often produces:

rather than the classic:

of pseudohypoparathyroidism.

Always check magnesium in unexplained hypocalcemia.

Modern Terminology

Add an educational callout:

Traditional terminology remains important

Students will still encounter:

• PHP type 1A;
• PHP type 1B;
• PHP type 1C;
• PHP type 2;
• pseudopseudohypoparathyroidism;
• progressive osseous heteroplasia.

However, the traditional classification became problematic because:

• phenotypes overlap;
• biochemical features vary with age;
• molecular mechanisms overlap;
• old functional tests are not widely available;
• molecular diagnosis can classify disease more accurately.

The 2018 international consensus concluded that the old subtype framework should be amended toward a common pathophysiological and molecular genetic classification. (Nature)

Ippsd Terminology

A newer umbrella terminology used in the literature is:

meaning:

This framework classifies disorders according to the affected signalling component rather than relying solely on historical phenotype labels.

However:

should remain the primary article title and SEO term because it remains widely recognized clinically and educationally.

Gnas: The Central Molecular Locus

Many classic PHP disorders involve:

GNAS encodes:

the stimulatory G-protein alpha subunit.

Gsα is required for signalling from multiple G-protein-coupled hormone receptors to:

and therefore:

Defective Gsα signalling can produce resistance not only to PTH but also to other hormones.

Why Gnas Is Complicated

GNAS is:

This means expression of maternal and paternal alleles differs among tissues.

Therefore:

can produce different clinical phenotypes depending on:

This is one of the most important principles in the entire article.

Maternal Vs Paternal Inheritance

In classic GNAS-related disease:

Maternal pathogenic GNAS defect

can produce:

historically:

Paternal pathogenic GNAS defect

can produce:

historically:

This occurs because GNAS expression is tissue-specific and parent-of-origin dependent. (NCBI)

Why The Kidney Is Special

The proximal renal tubule has important tissue-specific GNAS imprinting.

This helps explain why a maternal GNAS defect can cause:

while a paternal defect may not produce the same biochemical abnormality.

That would be wrong.

Use:

GNAS imprinting is tissue-specific, so parent of origin changes the phenotype in selected PTH-responsive tissues.

Classic Php1A

Teach historical PHP1A as:

typically with:

possible resistance to:

• TSH;
• gonadotropins;
• GHRH;
• other Gsα-coupled endocrine signals.

The phenotype can vary substantially between patients. (Nature)

Classic Php1B

Historically:

usually refers to disease with:

associated particularly with:

AHO features are usually absent or less prominent, although overlap can occur.

TSH resistance can also occur.

The phenotype is more variable than that old simplification.

Php1C

PHP1C was historically separated from PHP1A using biochemical functional assays.

Modern molecular understanding has shown substantial overlap.

Therefore:

Mention it as:

a historical subtype that substantially overlaps molecularly and clinically with PHP1A.

Php Type 2

PHP2 is an older physiological classification characterized historically by:

• preserved urinary cAMP response to PTH;
• impaired phosphaturic response.

The molecular basis is heterogeneous and incompletely defined.

Teach it as:

not as the central modern framework.

Endotext continues to describe the historical distinction but notes the heterogeneous nature of this group. (NCBI)

Albright Hereditary Osteodystrophy

AHO is a phenotype characterized by a combination of:

• brachydactyly;
• short stature;
• stocky build;
• round facial appearance;
• ectopic/subcutaneous ossification.

Not every patient has every feature.

The international consensus identifies brachydactyly type E and short adult stature relative to unaffected parents as major AHO criteria, with stocky build, round face and ectopic ossification as additional features. (Nature)

Brachydactyly

The classic hand phenotype often involves shortening of:

particularly:

although other bones may be affected.

A clenched fist may show:

sometimes called the:

Endotext describes characteristic shortening particularly involving the fourth and fifth metacarpals. (NCBI)

Early-Onset Obesity

Early-onset obesity can be a feature of some GNAS-related disorders.

The consensus considers:

especially when associated with TSH resistance or other characteristic findings, as one clue to the PHP-related disease spectrum. (Nature)

Ectopic Ossification

Some patients develop:

This is actual bone formation in soft tissue rather than simple calcium deposition.

Do not confuse:

with:

They are biologically different processes.

Pseudopseudohypoparathyroidism

Despite the confusing name, PPHP traditionally describes:

without:

Therefore patients may have:

while displaying AHO skeletal features.

Endotext describes this classical distinction. (NCBI)

Php Vs Pphp

Use this table:

Add:

This is a simplified teaching comparison; molecular phenotypes can overlap.

Multiple Hormone Resistance

Because Gsα participates in multiple receptor pathways, resistance may involve:

plus:

and sometimes:

• gonadotropins;
• GHRH;
• calcitonin-related signalling.

This is why PHP is not simply a calcium disorder.

The international consensus recommends systematic surveillance for multiple endocrine abnormalities. (Nature)

Tsh Resistance

TSH resistance may appear as:

with:

depending on severity.

It can precede obvious PTH resistance in some affected children.

Therefore thyroid function is an important part of evaluation and follow-up.

Growth Hormone Axis

Some patients, particularly in GNAS-related disorders, may have impaired:

leading to:

This can contribute to short stature.

Gonadal Axis

Gonadotropin resistance can contribute to:

• delayed puberty;
• incomplete pubertal development;
• menstrual abnormalities;
• reproductive dysfunction.

This is variable.

Neurocognitive And Developmental Features

Some affected patients can have:

• developmental delay;
• learning difficulties;
• cognitive impairment.

Phenotypic severity varies substantially.

Other Recognized Associations

Depending on molecular diagnosis, surveillance may need to consider:

• hearing impairment;
• sleep apnea;
• obesity;
• glucose intolerance;
• hypertension;
• dental abnormalities;
• ectopic ossification;
• neurological manifestations.

The consensus supports multidisciplinary surveillance extending beyond calcium metabolism. (Nature)

When Pth Resistance Appears

PTH resistance may:

Young children with an underlying molecular disorder may not initially have overt:

• hypocalcemia;
• hyperphosphatemia;
• markedly elevated PTH.

Therefore:

when characteristic phenotype/genetics are present.

Clinical Diagnosis

The international consensus identifies major clinical/biochemical clues including:

• PTH resistance;
• ectopic ossification;
• brachydactyly;
• early-onset obesity associated with other relevant abnormalities;
• AHO phenotype.

The diagnosis should integrate:

rather than relying on one physical feature. (Nature)

Molecular Confirmation

Modern diagnosis should seek the molecular or epigenetic cause where possible.

Testing may include evaluation for:

• GNAS sequence variants;
• GNAS methylation abnormalities;
• relevant deletions/duplications;
• other genes in the PTH/PTHrP signalling pathway when phenotype suggests them.

Use:

Testing strategy should be selected according to phenotype and specialist molecular-genetic assessment.

The consensus explicitly recommends molecular analysis to confirm the clinical diagnosis and characterize the subtype. (Nature)

Old Pth Infusion Test

Historically, exogenous PTH was administered to assess:

• urinary cAMP;
• phosphaturic response.

This helped distinguish old PHP subtypes.

However:

The international consensus states that the modified Ellsworth–Howard test is unnecessary for routine diagnosis and may be more relevant to research settings. (Nature)

Complete Diagnostic Algorithm

LOW / INAPPROPRIATELY NORMAL

→ HYPOPARATHYROIDISM PATHWAY

Internal link.

HIGH

LOW / LOW-NORMAL

Consider:

• vitamin D deficiency;
• malabsorption;
• secondary hyperparathyroidism.

HIGH

CKD present

→ evaluate CKD-MBD

Renal function does not explain pattern

Assess:

• brachydactyly;
• short stature;
• ectopic ossification;
• early-onset obesity;
• TSH resistance;
• family history;
• developmental phenotype.

Php Vs Hypoparathyroidism

Use:

Php Vs Vitamin D Deficiency

Php Vs Ckd-Mbd

Php Vs Primary Hyperparathyroidism

PHPT

The PTH signal is functioning.

PHP

The signal is being resisted.

This contrast is very useful for students.

Treatment Principle

Treatment is aimed at correcting:

and:

while avoiding:

and:

The main chronic treatment is:

with:

The international consensus identifies calcitriol or alfacalcidol, with or without calcium supplementation, as the mainstay of chronic treatment of hypocalcemia due to PTH resistance. (Nature)

Active Vitamin D

Use:

or:

where available.

Why?

Because renal PTH signalling that normally supports calcitriol synthesis is impaired.

Therefore active vitamin D bypasses part of the defective pathway.

Calcium Supplements

Calcium supplementation may be required when active vitamin D alone does not maintain appropriate calcium.

Treatment should be individualized according to:

• symptoms;
• serum calcium;
• phosphate;
• PTH;
• urine calcium;
• renal status.

Treatment Target Is Different From True Hypoparathyroidism

This is important.

In conventional hypoparathyroidism, clinicians often accept:

partly because absent PTH can lead to hypercalciuria.

In PTH resistance:

in important classic forms.

Therefore the treatment objective includes bringing:

while reducing excessive PTH without suppressing it too far.

The international consensus recommends aiming to keep serum PTH toward the upper part of the reference range rather than fully suppressing PTH. (Nature)

Why Not Suppress Pth Completely?

Persistently high PTH may contribute to:

But excessive treatment that suppresses PTH too strongly may increase:

Therefore the goal is:

Memory rule:

When Treatment May Begin Before Frank Hypocalcemia

The consensus states that active vitamin D treatment can be considered when PTH becomes:

even before overt hypocalcemia, depending on the clinical context. (Nature)

Present this as:

not a universal self-treatment threshold.

Phosphate

Treatment should aim to keep:

Active vitamin D and calcium treatment, by correcting hypocalcemia and reducing excessive PTH drive, are generally central.

Phosphate Binders

The international consensus states that phosphate binders other than calcium are:

for persistent hyperphosphatemia in PHP-related disorders. (Nature)

Pth Analogues

This is an important difference from chronic primary hypoparathyroidism.

The international consensus recommends:

because the underlying problem is:

rather than lack of hormone. (Nature)

Display this clearly.

Critical Contrast With Previous Article

Hypoparathyroidism

Hormone missing.

Modern management may include:

in selected inadequately controlled patients.

Pseudohypoparathyroidism

Hormone already elevated.

Problem:

Therefore:

This is a very high-value teaching contrast.

Monitoring Calcium, Phosphate And Pth

The consensus recommends monitoring:

• calcium;
• phosphate;
• PTH.

In stable asymptomatic patients:

was recommended in the international consensus, with more frequent testing when clinically indicated. (Nature)

Avoid turning this into an inflexible schedule.

Urinary Calcium

Hypercalciuria is generally less common than in true hypoparathyroidism because PTH action in the distal renal tubule can remain relatively preserved in classic PHP.

However:

particularly if treatment suppresses PTH excessively.

Therefore urinary calcium remains relevant when treatment is intensive or renal complications are suspected.

Nephrocalcinosis

The consensus recommends renal imaging:

• around transition from pediatric to adult care;
• and when persistent hypercalciuria occurs or clinical circumstances warrant.

Brain Calcification

Longstanding:

can be associated with intracranial calcification.

However:

The international consensus recommends brain CT primarily when neurological manifestations are present. (Nature)

Cataracts

Chronic mineral abnormalities can be associated with cataracts.

The international consensus supports ophthalmological evaluation as part of long-term assessment. (Nature)

Dental Health

Possible manifestations include:

• enamel hypoplasia;
• delayed eruption;
• abnormal tooth development;
• dental abnormalities related to chronic mineral disturbance.

Consensus recommendations support regular dental follow-up, especially during childhood. (Nature)

Weight And Metabolic Health

Some PHP-related disorders are associated with:

• early-onset obesity;
• glucose intolerance;
• metabolic complications.

Therefore long-term care should include appropriate:

• weight assessment;
• metabolic risk assessment;
• lifestyle support.

Multidisciplinary Care

Depending on phenotype, management may involve:

• endocrinology;
• pediatric endocrinology;
• clinical genetics;
• orthopedics;
• neurology;
• developmental services;
• nutrition;
• dentistry;
• ophthalmology;
• reproductive/endocrine care.

The consensus explicitly recommends multidisciplinary management. (Nature)

Complete Management Algorithm

Assess:

±

Target:

Monitor:

• Ca;
• PO₄;
• PTH;
• urinary calcium when appropriate;
• kidney;
• thyroid;
• growth/development;
• other hormone resistance.

Acute Symptomatic Hypocalcemia

If a patient develops:

• tetany;
• seizure;
• laryngospasm;
• significant arrhythmia;
• severe symptomatic hypocalcemia;

management follows emergency hypocalcemia principles:

plus:

and correction of contributing abnormalities such as magnesium disturbance.

Hypocalcemia

Molecular Diagnosis Algorithm

Create a separate educational algorithm:

Possible categories:

GNAS coding defect

GNAS methylation defect

Other PTH/PTHrP signalling disorder

Worked Case 1: Classic Pth Resistance

Patient:

• Ca 7.4 mg/dL;
• phosphate high;
• PTH markedly elevated;
• renal function normal.

First interpretation

PTH secretion is intact.

But high phosphate despite high PTH suggests:

Lesson

is the central biochemical clue.

Case 2: True Hypoparathyroidism

Patient:

• Ca low;
• phosphate high;
• PTH very low;
• previous total thyroidectomy.

Diagnosis

not pseudohypoparathyroidism.

Lesson

Same Ca/PO₄ pattern.

Different:

Case 3: Vitamin D Deficiency

Patient:

• Ca low-normal;
• PTH high;
• phosphate low;
• 25-OH D very low.

Interpretation

not PHP.

Key clue

rather than retained.

Case 4: Ckd

Patient:

• Ca low;
• phosphate high;
• PTH high;
• eGFR 18 mL/min/1.73 m².

Interpretation

provides a much more likely explanation.

Lesson

Always evaluate renal function before diagnosing PHP.

Case 5: Aho + Pth Resistance

Young patient:

• short stature;
• brachydactyly;
• round facial appearance;
• Ca low;
• PO₄ high;
• PTH high;
• mildly elevated TSH.

Interpretation

Classic phenotype suggesting a:

Next step

Case 6: Aho Without Pth Resistance

Patient:

• brachydactyly;
• short stature;
• ectopic ossification;
• normal Ca;
• normal phosphate;
• no evidence of hormone resistance.

Historical phenotype

Lesson

AHO does not automatically mean PTH resistance.

Case 7: Pth High Before Calcium Falls

Child with known molecular disease:

• calcium normal;
• phosphate upper-normal/high;
• PTH progressively rising.

Lesson

Biochemical PTH resistance can evolve before overt hypocalcemia.

Management and follow-up should be specialist guided.

Case 8: Tsh Resistance

Patient with established PHP:

• TSH elevated;
• free T4 low-normal.

Interpretation

Consider:

Lesson

PHP can involve multiple endocrine pathways.

Case 9: Short Stature

Patient with AHO phenotype has marked short stature.

Error

“All short stature is due to skeletal phenotype.”

Correct reasoning

Consider:

• skeletal phenotype;
• growth pattern;
• thyroid status;
• possible GH-axis abnormalities.

Case 10: Excessive Pth Suppression

Patient treated aggressively with active vitamin D and calcium:

• calcium high-normal;
• PTH suppressed;
• urinary calcium elevated.

Problem

Treatment has overshot.

Lesson

because some PTH activity can protect renal calcium handling.

Case 11: Pth Replacement Request

Patient asks why PTH replacement is used in true chronic hypoparathyroidism but not routinely in PHP.

Explanation

Hypoparathyroidism:

PHP:

Lesson

Case 12: Old Ellsworth–Howard Test

Student proposes an exogenous PTH challenge with urinary cAMP before diagnosis.

Modern approach

Routine diagnosis now relies on:

The old infusion test is generally unnecessary outside selected/research settings. (Nature)

Common Mistakes

Mistake 1

Pseudohypoparathyroidism means low PTH.

Wrong.

PTH is high.

Mistake 2

Hypoparathyroidism and PHP have identical PTH levels.

Wrong.

Mistake 3

High PTH always causes low phosphate.

Wrong if renal tissue is resistant to PTH.

Mistake 4

Low calcium + high PTH automatically means vitamin D deficiency.

Wrong.

Look at phosphate and renal function.

Mistake 5

High phosphate + high PTH automatically means PHP.

Wrong.

Exclude CKD.

Mistake 6

All PHP patients have AHO.

Wrong.

Mistake 7

All people with AHO have PTH resistance.

Wrong.

Mistake 8

PPHP means severe PTH resistance.

Wrong.

Historically it means AHO without classic hormone resistance.

Mistake 9

GNAS inheritance behaves like an ordinary autosomal dominant disorder with the same phenotype from either parent.

Wrong.

Parent-of-origin matters.

Mistake 10

Paternal GNAS expression is switched off in every tissue.

Wrong.

Imprinting is tissue-specific.

Mistake 11

PHP1A, 1B and 1C are perfectly distinct modern diseases.

Wrong.

There is substantial overlap.

Mistake 12

Old PTH infusion testing is mandatory.

Wrong.

Mistake 13

PHP affects only calcium.

Wrong.

Other hormone resistance can occur.

Mistake 14

TSH resistance is irrelevant.

Wrong.

Mistake 15

Brachydactyly alone diagnoses PHP.

Wrong.

Mistake 16

Ectopic ossification is simply calcium precipitation.

Wrong.

Mistake 17

PTH replacement should be given because the patient is hypocalcemic.

Wrong in PHP.

Mistake 18

Suppress PTH to zero with high-dose therapy.

Wrong.

Mistake 19

Renal monitoring is unnecessary.

Wrong.

Mistake 20

Normal calcium in early childhood excludes the disorder.

Wrong.

PTH resistance can evolve with age.

One-Minute Revision

but:

Look for:

Confirm with:

Treat with:

Target:

with:

Golden Rules

Pseudohypoparathyroidism is a disorder of PTH resistance, not PTH deficiency.

Low calcium should increase PTH, so high PTH in hypocalcemia indicates that the parathyroid glands are responding.

Low calcium + high phosphate + high PTH is the classic biochemical clue to PTH resistance.

Always consider CKD before diagnosing pseudohypoparathyroidism.

Vitamin D deficiency generally produces high PTH with low or low-normal phosphate.

The kidney is a major site of PTH resistance.

Many classic forms involve the GNAS signalling pathway.

GNAS is imprinted, so parent of origin matters.

AHO can include brachydactyly, short stature, stocky build, round facies and ectopic ossification.

AHO does not automatically prove PTH resistance.

PHP can involve resistance to hormones other than PTH, particularly TSH.

Traditional PHP subtype names remain useful, but molecular classification is increasingly preferred.

Molecular testing is central to confirming the diagnosis.

The old exogenous-PTH challenge is not routinely required.

Treatment uses active vitamin D with calcium when required.

PTH should be controlled but not completely suppressed.

PTH analogues are not routine treatment because the underlying problem is resistance to PTH.

Final Take-Home Section

Use this complete content:

Pseudohypoparathyroidism becomes much easier to understand when the question is changed from:

“Is PTH high or low?”

to:

When serum calcium falls:

In pseudohypoparathyroidism, it does.

But despite:

the kidney fails to produce an adequate response.

Therefore:

and:

The biochemical pattern becomes:

This differs from true hypoparathyroidism:

The next step is not simply to label the patient from the laboratory pattern.

First exclude important alternatives, especially:

Then assess the broader phenotype:

• brachydactyly;
• short stature;
• ectopic ossification;
• early-onset obesity;
• thyroid abnormalities;
• developmental features;
• family history.

Many classic disorders involve:

and because GNAS undergoes tissue-specific:

the parent from whom a pathogenic variant is inherited can substantially alter the phenotype.

Historical terms such as:

and:

remain useful for understanding older literature, but modern diagnosis should increasingly be based on:

Treatment aims to bypass the impaired PTH-dependent calcium/vitamin D pathway using:

with:

while keeping:

and:

Because PTH is already present and elevated:

The strongest final memory rule is:

Pseudohypoparathyroidism is best understood as a signalling disorder rather than a parathyroid-gland failure. The parathyroids recognize hypocalcemia and release PTH, but target tissues—particularly the kidney—do not respond normally. Recognizing that distinction explains the characteristic low-calcium, high-phosphate, high-PTH pattern and provides the basis for molecular diagnosis, treatment and lifelong surveillance.

Frequently Asked Questions